Isavuconazole utilization in a Spanish tertiary hospital. (PubMed, Rev Iberoam Micol) - Aug 23, 2026 - "The level of inappropriateness observed (15-30%) is relatively low compared to other studies on antifungal use, and the frequency of prescription does not exhibit a significant increase over the years. Although adherence to local and international prescribing guidelines remains suboptimal, these data demonstrate a relatively effective integration of isavuconazole into the hospital's therapeutic repertoire."
Journal • Hematological Disorders • Hematological Malignancies • Infectious Disease • Novel Coronavirus Disease • Pneumonia • Respiratory Diseases
|
|
Francisco Abad-Santos; Gina Mejía-Abril; Guillermo Fernández-Jiménez; Teresa López-Cuesta
|